Armis Advisers »

Gain Therapeutics shares owned by Armis Advisers

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Armis Advisers from 13F filings

Historical chart of Armis Advisers investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Armis Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Armis Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 11k 1.84
2025-06-30 $19k 11k 1.73
2025-03-31 $22k 11k 2.05

More positions owned by Armis Advisers

Listed Fds Tr Shares Lag Cap (OVL)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Listed Fds Tr Overlay Shares (OVLH)
Vanguard Index Fds Growth Etf (VUG)
Listed Fds Tr Overlay Shs Shrt (OVT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard World Mega Cap Val Etf (MGV)

View all positions for Armis Advisers

Top funds holding Gain Therapeutics

Jones Financial Companies, L.L
DME Capital Management
Vanguard Group
Citadel Advisors
Geode Capital Management
Cambridge Investment Research Advisors
Marshall Wace
UBS Group
Renaissance Technologies
BlackRock
State Street Corporation
Northern Trust
Susquehanna International
Morgan Stanley
Jane Street

View all funds holding Gain Therapeutics